Treatment commonly begins with months of multi-drug chemotherapy regimen. Either R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) or DA-EPOCH-R (dose-adjusted etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin, rituximab) has been typical. Other, more intense, regimens may be more effective. Radiation therapy may be added, especially if chemotherapy does not seem sufficient on its own. Radiation may cause other health problems later, such as breast cancer, and there is some debate about the best approach to it. FDG-PET scanning is not as useful for predicting treatment success in<unk>  as it is in other lymphomas.
Primary mediastinal B-cell lymphoma
Thymic carcinoma
Thymoma with immunodeficiency
Tuberculous lymphadenitis
Nodal marginal zone B cell lymphoma
Primary effusion lymphoma
Gray zone lymphoma
Thymoma-associated multiorgan autoimmunity